Sen S, Khalid H, Udaya P, Raman R, Rajendram R, ElHousseini Z
Indian J Ophthalmol. 2024; 73(Suppl 1):S7-S23.
PMID: 39723865
PMC: 11834929.
DOI: 10.4103/IJO.IJO_878_24.
Venkatesh R, Jayadev C, Prabhu V, Gandhi P, Kathare R, Yadav N
World J Methodol. 2024; 14(4):92246.
PMID: 39712567
PMC: 11287545.
DOI: 10.5662/wjm.v14.i4.92246.
Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S
J Clin Med. 2024; 13(23).
PMID: 39685795
PMC: 11642061.
DOI: 10.3390/jcm13237336.
Shimura M, Hirano T, Tsuiki E, Takamura Y, Morizane Y, Akiyama K
Retina. 2024; 45(2):335-344.
PMID: 39423137
PMC: 11753449.
DOI: 10.1097/IAE.0000000000004301.
Yiu G, Hang A, Fong R
J Vitreoretin Dis. 2024; 8(3):355-358.
PMID: 38770082
PMC: 11102732.
DOI: 10.1177/24741264241240320.
Effectiveness of intravitreal ranibizumab for diabetic macular edema in vitrectomized versus non-vitrectomized eyes: a Meta-analysis.
Wang Y, Xu Q, Luan J
Int J Ophthalmol. 2024; 17(4):729-735.
PMID: 38638245
PMC: 10988062.
DOI: 10.18240/ijo.2024.04.18.
Effect of aflibercept combined with triamcinolone acetonide on aqueous humor growth factor and inflammatory mediators in diabetic macular edema.
Li D, Liao H, Zhang J, Qin B
Int J Ophthalmol. 2024; 17(2):297-303.
PMID: 38371257
PMC: 10827616.
DOI: 10.18240/ijo.2024.02.11.
Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial.
Guo H, Li W, Nie Z, Zhang X, Jiao M, Bai S
Trials. 2023; 24(1):685.
PMID: 37875997
PMC: 10594908.
DOI: 10.1186/s13063-023-07735-w.
The Role of Müller Cells in Diabetic Macular Edema.
Lai D, Wu Y, Shao C, Qiu Q
Invest Ophthalmol Vis Sci. 2023; 64(10):8.
PMID: 37418272
PMC: 10337800.
DOI: 10.1167/iovs.64.10.8.
Current Treatments for Diabetic Macular Edema.
Tatsumi T
Int J Mol Sci. 2023; 24(11).
PMID: 37298544
PMC: 10253534.
DOI: 10.3390/ijms24119591.
Pathological Neurovascular Unit Mapping onto Multimodal Imaging in Diabetic Macular Edema.
Murakami T, Ishihara K, Terada N, Nishikawa K, Kawai K, Tsujikawa A
Medicina (Kaunas). 2023; 59(5).
PMID: 37241128
PMC: 10221113.
DOI: 10.3390/medicina59050896.
Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema.
Ranno S, Vujosevic S, Mambretti M, Metrangolo C, Alkabes M, Rabbiolo G
J Clin Med. 2023; 12(6).
PMID: 36983298
PMC: 10056256.
DOI: 10.3390/jcm12062297.
Hyperreflective Membrane at the Vitreoretinal Interface in Diabetic Macular Edema: A Finding in Ultra-High-Resolution Optical Coherence Tomography.
Wada I, Nakao S, Arima M, Ishikawa K, Yamaguchi M, Kaizu Y
Transl Vis Sci Technol. 2022; 11(9):21.
PMID: 36149646
PMC: 9520517.
DOI: 10.1167/tvst.11.9.21.
Systemic and vitreous biomarkers - new insights in diabetic retinopathy.
Pessoa B, Heitor J, Coelho C, Leander M, Meneres P, Figueira J
Graefes Arch Clin Exp Ophthalmol. 2022; 260(8):2449-2460.
PMID: 35325286
DOI: 10.1007/s00417-022-05624-7.
Intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy: a systematic review.
Dervenis P, Dervenis N, Steel D, Sandinha T, Tranos P, Vasilakis P
Ther Adv Ophthalmol. 2021; 13:25158414211059256.
PMID: 34901749
PMC: 8655445.
DOI: 10.1177/25158414211059256.
Vitrectomized versus non-vitrectomized eyes in diabetic macular edema response to ranibizumab-retinal layers thickness as prognostic biomarkers.
Pessoa B, Leite J, Heitor J, Coelho J, Monteiro S, Coelho C
Sci Rep. 2021; 11(1):23055.
PMID: 34845300
PMC: 8630028.
DOI: 10.1038/s41598-021-02532-4.
Comparison of anatomical and functional outcomes of vitrectomy with internal limiting membrane peeling in recalcitrant diabetic macular edema with and without traction in Indian patients.
Vikas S, Agarwal D, Seth S, Kumar A, Kumar A
Indian J Ophthalmol. 2021; 69(11):3297-3301.
PMID: 34708792
PMC: 8725148.
DOI: 10.4103/ijo.IJO_1271_21.
Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy.
Tomita Y, Lee D, Tsubota K, Negishi K, Kurihara T
J Clin Med. 2021; 10(20).
PMID: 34682788
PMC: 8537579.
DOI: 10.3390/jcm10204666.
Possible roles of anti-type II collagen antibody and innate immunity in the development and progression of diabetic retinopathy.
Ikeda T, Nakamura K, Kida T, Oku H
Graefes Arch Clin Exp Ophthalmol. 2021; 260(2):387-403.
PMID: 34379187
PMC: 8786754.
DOI: 10.1007/s00417-021-05342-6.
Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Treatment-Naïve Diabetic Macular Edema: A Prospective, Uncontrolled Pilot Study.
Rush R, Rush S
Clin Ophthalmol. 2021; 15:2619-2624.
PMID: 34188440
PMC: 8232852.
DOI: 10.2147/OPTH.S320214.